Mesoblast Ltd MSB.AX :
* MESOBLAST ENTERS GLOBAL COLLABORATION FOR DEVELOPMENT, MANUFACTURE AND COMMERCIALIZATION OF REMESTEMCEL-L
* MESOBLAST LTD - ENTERED LICENSE & COLLABORATION AGREEMENT WITH NOVARTIS FOR DEVELOPMENT, MANUFACTURE, COMMERCIALIZATION OF REMESTEMCEL-L
* MESOBLAST LTD - NOVARTIS WILL MAKE $50 MILLION UPFRONT PAYMENT INCLUDING $25 MILLION IN EQUITY IN AGREEMENT
* MESOBLAST LTD - CO MAY RECEIVE TOTAL OF $505 MILLION PENDING ACHIEVEMENT OF PRE-COMMERCIALIZATION MILESTONES FOR ARDS INDICATIONS IN AGREEMENT
* MESOBLAST LTD - CO MAY RECEIVE ADDITIONAL PAYMENTS POST-COMMERCIALIZATION OF UP TO $750 MILLION